Stockwinners Market Radar for May 24, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:06 EDT Cathie Wood's ARK Investment bought 100K Adaptive Biotechnologies shares today

19:50 EDT DXP Enterprises names David Molero Chief Accounting Officer - DXP Enterprises announced that David Molero has been appointed as DXP's new Chief Accounting Officer, effective May 22, 2023. Mr. Molero will be an integral leader on the accounting and finance team overseeing the Company's accounting, tax, SOX, and SEC reporting functions, and will be reporting directly to Kent Yee, SVP and Chief Financial Officer.

19:10 EDT DoorDash exec sells $818.6K in common stock - In a regulatory filing, DoorDash disclosed that its General Counsel Tia Sherringham sold 12.2K share of common stock on May 22nd in a total transaction size of $818.6K

19:00 EDT PennyMac Financial president Jones sells 19,820 common shares - In a regulatory filing, PennyMac Financial Services president Doug Jones disclosed the sale of 19,820 common shares of the company on May 22 at a price of $62.3888 per share.

18:48 EDT Royalty Pharma CEO Legorreta buys 150,000 class A ordinary shares - In a regulatory filing, Royalty Pharma CEO and chairman Pablo Legorreta disclosed the purchase of 150,000 class A ordinary shares of the company on May 24 at a price of $32.2496 per share.

18:29 EDT Bachoco to initiate delisting process in Mexico - Industrias Bachoco informs that its Board of Directors, with the abstention in the deliberation and voting, and without the presence of, directors who are members of the Robinson Bours Family, has resolved, considering, mainly, that, to date, approximately 2.5% of the shares representing its outstanding capital stock are held by the investing public, and, therefore: (i) the costs of maintaining such shares registered in the National Securities Registry maintained by the National Banking and Securities Commission, and listed on the Mexican Stock Exchange (Bolsa Mexicana de Valores, S.A.B. de C.V.), exceed its benefits, and (ii) Bachoco is not in compliance with the requirements to maintain the listing of shares representing its capital stock on the Mexican Stock Exchange, pursuant to rule 4.033.01 and others applicable, of the Internal Regulations of said stock exchange, and it does it have a program aimed at correcting the lack of compliance, in accordance with the aforementioned Regulations, which, in turn, in accordance with the Mexican Securities Market Law, may cause the suspension of the listing of the shares representing the capital stock of Bachoco and/or the cancellation of its registration before the Mexican National Securities Registry; that Bachoco initiates, in the near future, the processes to promote the cancellation of the registration of the shares representing its capital stock in the National Securities Registry and its delisting from the Mexican Stock Exchange, including without limitation, convening an Extraordinary Shareholders Meeting to propose the aforementioned actions, and initiating the processes before the National Banking and Securities Commission, so that the issuer itself. or a third party, may carry out a tender offer acquisition in Mexico, of the shares representing its capital stock that, as of the start date of said offer, are held by public investors, in terms of article 108 of the Mexican Securities Market Law, at a price determined in accordance with said article.

18:09 EDT Freshpet says attempts to reach 'constructive resolution' with Jana rejected - Freshpet issued the following statement in response to JANA Partners LLC's May 24, 2023 press release: "Over the past nine months since JANA publicly disclosed its potential director nominees, the Company has engaged with JANA extensively to understand their perspectives and address their concerns. The Freshpet Board welcomes constructive ideas, from any source, that will drive shareholder value. Unfortunately, JANA has made clear to us that their sole purpose is to force a sale of the Company without consideration of all potential paths to value creation. Despite the difference of perspectives, the Board has attempted to reach a constructive resolution with JANA but its offers were rejected. We remain hopeful to avoid a distracting proxy fight as the management team continues to focus on driving growth and margin expansion as demonstrated in recent quarterly performance. The Board and management remain focused on driving shareholder value and building on the significant momentum in our business. Recent results and guidance demonstrate strong operational momentum and growth. The Freshpet Board and management are making strong progress executing our strategy. We grew revenue by 27% in Q1 2023 while continuing to improve performance in logistics, quality, and other operational areas of our business. Looking ahead, we expect continued strong revenue growth and adjusted gross margin expansion for full year 2023... Freshpet's independent Board has the right skills and expertise to oversee management and drive shareholder value creation. Freshpet recently announced several actions designed to ensure that the Board continues to have the appropriate skills, expertise and independence to effectively oversee management and its execution of the strategy. Walter George, current Chair of the Nominating, Governance and Sustainability Committee, will be appointed the new independent Chair of the Board effective immediately following the Company's 2023 Annual Meeting. Accordingly, Charles Norris, Chair of the Board, will not stand for reelection at the 2023 Annual Meeting as he has reached the mandatory retirement age put in place as part of the Company's long-term governance plan in 2020. Former Conagra Chief Supply Chain Officer David B. Biegger was also appointed to the Board, following a search by a leading third-party executive search firm, and will serve on the Audit Committee. We will continue to regularly evaluate the Board's skillsets and composition to make sure it is well positioned to oversee and guide management as we continue to execute our strategy."

18:01 EDT NioCorp to be added to Russell 3000 Index - NioCorp Developments is pleased to announce that it is set to join the broad-market Russell 3000 Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023, according to a preliminary list of additions posted May 19, 2023.

17:41 EDT Nike: CFO Matthew Friend expands role, COO Campion to managing director role - Nike announced senior leadership changes today that will continue to build on its strong momentum and underscore Nike's commitment to product innovation, serving athletes and unrivaled brand storytelling while driving deeper integration across the business. Heidi O'Neill, currently President, Consumer & Marketplace, will become President, Consumer, Product & Brand, NIKE, and Craig Williams, currently President, Jordan Brand, will become President, Geographies & Marketplace, NIKE, Matthew Friend, EVP & Chief Financial Officer, NIKE, will expand his responsibilities to include Procurement, Global Places & Services and Demand and Supply Management. "We're driving even greater focus and integration across our business and teams through these changes, doubling down on what Nike does best: seamlessly serving athletes with compelling product," said John Donahoe, President & CEO, NIKE O'Neill most recently served as Nike's President, Consumer & Marketplace, leading Nike's marketplace and four geographic operating regions. Previous roles included President, Nike Direct, accelerating Nike's retail and digital-commerce business. O'Neill was also responsible for creating and leading Nike Women's business. Sarah Mensah, Vice President/GM, North America, will become President, Jordan Brand. Scott Uzzell, currently CEO, Converse will become Vice President/GM, North America, reporting to Williams. Uzzell's successor will be named shortly. Jordan Brand and Converse will report to John Donahoe. Andy Campion, Chief Operating Officer, will take on a new leadership role as Managing Director, Strategic Business Ventures. In his new role, Campion will work closely with Donahoe to identify and pursue new business opportunities to drive disproportionate growth for the company. As part of his new role, Campion will oversee Nike Virtual Studios and lead teams across Nike's World Headquarters and Los Angeles-based offices. Michael Spillane, President, Consumer Creation will retire from NIKE, Inc. later in 2023 after 16 years with the company. We thank Michael for his extensive contributions to the brand.

17:32 EDT BrainStorm COO David Setboun resigns - In a regulatory filing, BrainStorm disclosed that on May 18, David Setboun, PhD, MBA, Executive Vice President and COO, notified the company of his decision to resign from his role effective as of May 31 to pursue another opportunity. Dr. Setboun's decision to resign was not due to any disagreement with the company on any matter, or relating to its operations, policies, or practices.

17:25 EDT Jupiter Wellness Acquisition Corp trading halted, news pending

17:15 EDT Royal Caribbean director Wilhelmsen sells $47M in shares - Director of Royal Caribbean Cruises Arne Wilhelmsen disclosed in a regulatory filing that he had sold 578,800 shares of company stock at $80.53 per share between May 22 and May 23 for a total transaction amount of $46,610,359.

17:12 EDT FG Merger Corp. intends to extend deadline for initial business combination - FG Merger Corp. notified the trustee of the company's trust account of its intention to extend the time available to the company to consummate its initial business combination from June 1 to September 1, in accordance with the terms of FGMC's governing documents. In connection with the Extension, FG Merger Investors, the company's sponsor, its affiliates or designees, must deposit an aggregate of $805K into the company's trust account prior to June 1, on behalf of the company. FGMC will issue a press release the day after the applicable deadline announcing that the funds have been timely deposited. The extension provides FGMC with additional time to complete its proposed business combination with iCoreConnect.

17:01 EDT Qurate Retail to sell Zulily to Regent - Qurate Retail "announced that Regent, a Los Angeles-based investment firm with proven expertise in the retail and apparel sectors, has acquired Zulily, the online retailer delivering a fun shopping experience helping moms discover exclusive daily deals, brand names and on-trend styles, and everyday value on clothing, footwear, homeware essentials and more. Zulily was a wholly owned subsidiary of Qurate Retail, the largest player in video commerce through its QVC and HSN businesses and the owner of Cornerstone Brands. The divestiture aligns with Qurate Retail's Project Athens transformation strategy articulated in June 2022 to optimize its brand portfolio. In connection with the transaction, Zulily will no longer be a co-borrower in QVC, Inc.'s bank credit facility and Qurate Retail repaid Zulily's outstanding borrowing, which was approximately $80 million as of closing. QVC, Inc.'s leverage as defined in its credit agreement as of March 31, 2023, assuming the Zulily divestiture had occurred prior to such date, would have been reduced to 2.3x. Based on the terms of the sale agreement, there is potential for Qurate Retail to receive an earnout in future years. "

16:48 EDT American Eagle falls 15% to $10.22 after Q2, FY revenue guidance disappoints

16:46 EDT EVgo director buys $25M in common stock - In a regulatory filing, EVgo disclosed that its director David Nanus bought 5.88M shares of common stock on May 22nd in a total transaction size of $25.0M.

16:38 EDT Ellington Financial reports estimated book value per share $14.89 on April 30 - This estimate includes the effect of the previously announced monthly dividend of 15c per share of common stock, payable on May 25 to holders of record on April 28, with an ex-dividend date of April 27.

16:37 EDT Mirati Therapeutics falls 10% after SAPPHIRE study did not meet primary endpoint - In after-hours trading, shares are down 10% to $39.51.

16:33 EDT Energy Services of America receives Nasdaq listing non-compliance notification - Energy Services of America received a delinquency notification letter from Nasdaq indicating that the company is not in compliance with the continued listing requirements under Nasdaq Listing Rules because the company did not timely file its Quarterly Report on Form 10-Q for the period ended March 31. The notification letter has no immediate effect on the listing or trading of the company's common stock on Nasdaq. The company filed a Notification of Late Filing on May 15 indicating that the filing of the Form 10-Q would be delayed due to the need to restate the company's previously issued audited consolidated financial statements for the fiscal years ended September 30, 2022 and 2021 and certain related interim periods. The company must submit a plan of compliance no later than July 17 addressing how it intends to regain compliance with Nasdaq's listing rules and, if Nasdaq accepts the Plan, it may grant an extension of up to 180 calendar days from the Form 10-Q original filing due date, or until November 13, to regain compliance. The company's management is working diligently to complete the Form 10-Q and intends to file the Form 10-Q as soon as practicable.

16:32 EDT Rocket Lab preparing for second TROPICS launch from Mahia Peninsula, NZ - Rocket Lab is preparing for the second of two dedicated Electron launches to deploy a constellation of storm monitoring satellites for NASA. This mission, named Coming To A Storm Near You, is scheduled for lift-off no earlier than 16:00 NZST on May 25th from Launch Complex 1 on New Zealand's Mahia Peninsula.

16:30 EDT Mirati Therapeutics trading resumes

16:22 EDT TScan Therapeutics names Gavin MacBeath permanent CEO - TScan Therapeutics announced that its board of directors has appointed Gavin MacBeath as CEO of TScan and as a Class I Director of its board, each effective as of May 24. MacBeath, has been serving as acting CEO since March 2023. MacBeath will no longer serve as chief scientific and operating officer of the company, effective May 24.

16:20 EDT EnerSys sees FY24 capital expenditures $120M

16:19 EDT Trex Company CFO Dennis Schemm to step down - Trex "announced that Dennis Schemm has resigned as Senior Vice President and Chief Financial Office rto accept a position in a southern region state closer to family."

16:17 EDT Staffing 360 Solutions gets Nasdaq letter on listing requirements compliance - Staffing 360 Solutions reported that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c) as a result of not having timely filed its Quarterly Report on Form 10-Q for the quarter ended April 1 with the Securities and Exchange Commission.

16:15 EDT Bogota Financial adopts, receives regulatory approval of fourth buyback - Bogota Financial announced that it has received regulatory approval for the repurchase of up to 249,920 shares of its common stock, which is approximately 5% of its outstanding common stock, as previously approved by the board of directors of the company. This is the company's fourth stock repurchase program. Shares may be repurchased in open market or private transactions or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission.

16:10 EDT Zuora reports Q1 ARR up 15% from last year - The company states: "Customers with ACV equal to or greater than $100,000 were 782, up from 746 as of April 30, 2022. Given that 96% of our customers have ACV over $100,000, we will no longer report on this metric and will instead report on customers with ACV equal to or greater than $250,000, which we believe to be a more meaningful measure of our execution and continued focus on enterprise customers. Customers with ACV equal to or greater than $250,000 were 436, up from 386 as of April 30, 20221. Dollar-based retention rate was 108%, compared to 110% as of April 30, 2022. ARR was $373.9 million compared to $326.3 million as of April 30, 2022, representing ARR growth of 15%."

16:08 EDT Snowflake sees FY24 product revenue at $2.6B, up 34% from last year

16:05 EDT Kubient trading halted, news pending

16:03 EDT Annexon announces ARCHER trial endpoint did not reach statistical significance - Annexon announced topline results from its ARCHER Phase 2 trial of ANX007 in patients with geographic atrophy, or GA. Results from the 12-month treatment period of ARCHER showed that patients treated monthly and every-other-month with ANX007 were protected against vision loss as measured by changes from baseline in the widely accepted functional endpoint of best corrected visual acuity, or BCVA. Patients in the monthly treatment group showed a 72% reduction in risk of 15-letter loss and patients in the every-other-month treatment group showed a 48% reduction in risk of 15-letter loss. Patients in the pooled treatment group showed a 59% reduction in risk of greater than15-letter loss. These data represent the first demonstration of a complement-based therapy to protect against vision loss in a prospective 12-month clinical trial and support the differentiated mechanism of action of ANX007, which is designed to target and preserve photoreceptor cells, synapses and function. The primary endpoint of mean rate of change in GA lesion area compared to sham at 12 months did not reach statistical significance. A 6.2% reduction in lesion growth was observed in monthly treatment group (p=0.526), a 1.3% reduction was observed in the every-other-month treatment group and a 3.7% reduction was observed in the pooled patient population. ANX007 was generally well tolerated as both a monthly and every-other-month treatment.

16:00 EDT Mirati Therapeutics trading halted, news pending

15:31 EDT Sinclair Broadcast shareholders approve company reorganization - Sinclair Broadcast Group announced that, at a special meeting, its stockholders approved the previously announced reorganization, in the form of a share exchange, in which a new holding company, Sinclair, Inc., will become the publicly-traded parent of the company and its subsidiaries. The Reorganization is expected to close in the second quarter of 2023. In the Reorganization, each outstanding share of the company's Class A common stock and Class B common stock will be exchanged automatically on a one-for-one basis for a share of Class A common stock and Class B common stock, respectively, of New Sinclair. New Sinclair's Class A common stock will continue to trade on the Nasdaq Global Select stock market under the ticker symbol "SBGI" just as the company's Class A common stock does today. The rights and benefits of the holders of shares of New Sinclair's common stock, including voting rights, will be the same as the rights and benefits of the holders of shares of the company's common stock in all material respects. The Reorganization is not expected to result in a change in the directors, executive officers, management or business of the public company, or to impact the timing of the declaration and payment of our regular quarterly dividends. The Reorganization is not expected to result in gain or loss to the company's stockholders for U.S. federal income tax purposes.

15:18 EDT Texas Attorney General files lawsuit against Hilton for misleading consumers - Attorney General Paxton filed a lawsuit against Hilton (HLT) for misleading consumers about the true costs of hotel rooms in violation of Texas consumer protection laws. The lawsuit, filed against the company comes after Paxton recently filed a lawsuit against Hyatt (H) and settled claims against Marriott (MAR) for similar behavior. "Heightened inflation and worsening economic conditions have made it an even more pressing priority to protect Americans from predatory, illegal corporate practices," said Attorney General Paxton. "Many major hotel chains, including Hilton, have been deceiving their customers for far too long. I warned these companies they would face consequences for this behavior, and Texas has delivered aggressive action to protect consumers, promote price transparency in the hotel and travel industries, and ensure that companies violating our laws are held responsible for misleading the public." Reference Link

14:45 EDT BWM presents new electric i5 BMW - BMW has unveiled its new BMW i5 during a digital world premiere on Wednesday. "More dynamic than ever, featuring a wealth of digital innovations and, for the first time, all-electric drive - this is how the new BMW 5 Series Sedan steps up to the plate. As the BMW i5, the new edition of the world's most successful business sedan takes the lead on the road to sustainable premium mobility in the upper mid-range vehicle segment," the company said. At launch, BMW will offer two all-electric options for the i5: the single-motor rear-wheel drive i5 eDrive40 or the high-performance M60 xDrive model. "The space-saving high-voltage battery is located in the underbody and provides a usable energy content of 81.2 kWh. In addition to the efficient electric motors, the latest version of adaptive recuperation and an intelligent combination of heat pump technology for heating and cooling the interior, drive and high-voltage battery contribute to the long range. The respective WLTP values are 282 - 320 miles for the BMW i5 M60 xDrive and 309 - 361 miles for the BMW i5 eDrive40. With the new MAX RANGE function, the range can be increased by up to 25 percent if required by limiting power and speed and deactivating comfort functions," BMW adds.Reference Link

13:28 EDT Avid Technology jumps 13% to $23.20 after Reuters says company exploring sale

13:11 EDT North American rail traffic down 4.8% for the week ending May 20 - The Association of American Railroads AAR reported U.S. rail traffic for the week ending May 20. For this week, total U.S. weekly rail traffic was 470,694 carloads and intermodal units, down 5.2% compared with the same week last year. Total carloads for the week ending May 20 were 225,093 carloads, down 0.4% compared with the same week in 2022, while U.S. weekly intermodal volume was 245,601 containers and trailers, down 9.3% compared to 2022. North American rail volume for the week ending May 20, on 12 reporting U.S., Canadian and Mexican railroads totaled 330,235 carloads, up 0.3% compared with the same week last year, and 331,392 intermodal units, down 9.3% compared with last year. Total combined weekly rail traffic in North America was 661,627 carloads and intermodal units, down 4.8%. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC) ,Union Pacific (UNP), Wabtec (WAB), FreightCar America (RAIL), Trinity Industries (TRN) and Greenbrier (GBX). Reference Link

13:05 EDT Jupiter Wellness Acquisition Corp trading halted, volatility trading pause

12:31 EDT TowneBank boosts quarterly dividend to 25c from 23c per share - TowneBank declared its Q2 cash dividend of 25c per common share, payable on July 14, to shareholders of record on June 30. The quarterly common stock cash dividend is an 8.7% increase from the previous dividend rate.

12:02 EDT Nio falls -10.7% - Nio is down -10.7%, or -94c to $7.81.

12:02 EDT Global Net Lease falls -11.3% - Global Net Lease is down -11.3%, or -$1.20 to $9.37.

12:01 EDT QuantaSing Group Ltd- ADR trading resumes

12:00 EDT Alerian Midstream Energy Index rises 1250.5% - Alerian Midstream Energy Index is up 1250.5%, or $448.53 to $484.40.

11:52 EDT Canadian Pacific Kansas City 'has really hit the ground running,' says Pershing

11:37 EDT Priority Technology enters stalking horse agreement with Plastiq - Priority Technology Holdings has entered into a definitive agreement as the stalking horse bidder to acquire substantially all of the assets of Plastiq, Inc and certain of its affiliates in its Chapter 11 Restructuring. The Purchase Agreement is subject to Bankruptcy Court approval. Plastiq is a B2B payments platform that offers bill pay and instant access to working capital to small and midsize businesses.

11:33 EDT Restaurant Brands making 'great progress' in growing brands, says Pershing

11:25 EDT Chipotle an 'extremely compelling long-term investment,' says Pershing Square

11:20 EDT 'Much more to come' on Chipotle's operations front, says Pershing

11:12 EDT Microchip reiterates prior guidance on backlog confidence - Regarding the company's September quarter, Microchip said "it is very unlikely that it will be down. We haven't got it flat; we haven't got it up. The confidence to make that statement is really driven by the backlog that we have in place and the manufacturing capacity we have in place to be able to drive that. We're in a good position and the thoughts regarding September quarter have not changed." Microchip said at the JPMorgan 51st Annual Global Technology, Media & Communications Conference. The Fly notes that chip maker Analog (ADI) was under pressure on Wednesday after guiding to third quarter EPS view that missed analyst expectations. Shares of Microchip have dropped almost 6% in Wednesday morning trading.

11:05 EDT Pershing Square sees 'significant' margin opportunity at Google

11:02 EDT Union Pacific, BLET reach tentative agreement to improve work schedules - The Brotherhood of Locomotive Engineers and Trainmen and Union Pacific Railroad announced a tentative agreement that enhances the quality of life for Union Pacific's locomotive engineers and their families by making it possible for them to have more predictable schedules. It also will enable the railroad to better manage staffing levels, which supports more consistent and reliable service. The tentative agreement provides locomotive engineers with an 11 days on, 4 days off schedule. Union Pacific expects to make meaningful progress implementing the new work/rest schedules within a year of ratification.

10:54 EDT Enveric Biosciences eliminates positions of President, Chief Operating Officer - In a regulatory filing earlier, Enveric Biosciences disclosed that on May 15, the company announced budget cuts that led to an approximately 35% reduction in force, or "RIF. "Following the RIF, on May 18, 2023, the company eliminated the positions of President and Chief Operating Officer. Accordingly, pursuant to the employment agreement between the company and Avani Kanubaddi dated December 2, 2020, the company terminated the employment contract of Mr. Kanubaddi without cause, the President and Chief Operating Officer of the Company, to be effective June 17," the filing stated.

10:22 EDT Minority Equality Opportunities postpones special meeting of shareholders - Minority Equality Opportunities Acquisition filed a definitive proxy statement / final prospectus with respect to a special meeting of its stockholders to be held on Wednesday, May 24, 2023 at 10:00 a.m. to vote on, among other things, a proposal to adopt and approve that certain Business Combination Agreement by and among MEOA, Digerati Technologies, Inc. and MEOA Merger Sub, Inc., and the business combination contemplated thereby. On May 24, 2023, MEOA determined to postpone the Special Meeting until 10:00 a.m. EDT on Friday, May 26, 2023. Based upon the preliminary reports that have been provided to MEOA, the holders of an aggregate of 728,815 public shares of MEOA's Class A common stock have submitted requests that their public shares be redeemed in connection with the Special Meeting, with these redemptions only taking effect upon the closing of the Business Combination. At the closing of the Business Combination, an aggregate of 52,013 public shares shall remain outstanding. This amount takes into account the redemptions discussed in this paragraph plus the redemptions that were requested and that took effect in connection with MEOA's special meeting of stockholders held on May 23, 2023.

10:19 EDT BAE Systems awarded $2.2B contract by the Czech Republic - The Czech Republic has completed negotiations with the government of Sweden, the Swedish defense procurement organization FMV, and BAE Systems Hagglunds to buy 246 CV90 MkIV infantry fighting vehicles in seven different variants. The contract is valued at SEK 22B. The agreement provides highly-capable vehicles for Czech soldiers while providing Czech industry a significant role in the program. The CV90s will be developed and delivered through an industrial partnership with Czech industry to meet the requirements of the Czech Ministry of Defence and the intention of maintaining national sovereignty for the Czech Republic. The Czech industrial partners will be delivering 40% of the acquisition's value in development, production and assembly contracts, not including VAT.

10:04 EDT Natural Alternatives adds U.S. manufacturing facility in California - Natural Alternatives International announced the expansion of its global dietary supplement contract manufacturing network, providing the ability to better service existing customers, attract new customers, expand sales, and provide potential for channel and customer diversification. The high-volume powder blending and packaging facility will provide an annual plant capacity of over 26 million pounds of powder. The new facility employs 84 and is comprised of 54,154 square feet of manufacturing and warehouse space for raw material and finished product storage. New equipment technologies include two 400 cubic foot fluidizing paddle blenders, high speed rotary pouchers, and gravity flow racking.

10:00 EDT Goldenbridge Acquisition Ltd trading resumes

10:00 EDT Agilent falls -10.1% - Agilent is down -10.1%, or -$12.96 to $115.68.

10:00 EDT Kohl's rises 10.6% - Kohl's is up 10.6%, or $2.05 to $21.32.

10:00 EDT Alerian Midstream Energy Index rises 1248.9% - Alerian Midstream Energy Index is up 1248.9%, or $447.97 to $483.84.

09:47 EDT Agilent falls -10.0% - Agilent is down -10.0%, or -$12.84 to $115.80.

09:47 EDT Global Net Lease falls -14.5% - Global Net Lease is down -14.5%, or -$1.53 to $9.03.

09:47 EDT Abercrombie & Fitch rises 18.1% - Abercrombie & Fitch is up 18.1%, or $4.17 to $27.18.

09:43 EDT Zura Bio Ltd trading resumes

09:38 EDT JX Luxventure meets requirements for continued listing on Nasdaq - JX Luxventure announced that on May 23, 2023, the Company received the letter from the Nasdaq Hearing Panel stating that, as determined by the Nasdaq Listing Qualifications Department, the Company cured its deficiency related to the minimum bid requirement for continued listing on the Nasdaq Capital Market and the hearing previously scheduled on May 25, 2023, before the Nasdaq Hearing Panel has been canceled. This letter also stated that the Company is in compliance with all applicable continued listing standards and that its stock will continue to be listed and traded on Nasdaq.

09:32 EDT Appian opens new EMEA headquarters in London - Appian announced the opening of its new regional headquarters in the City of London. Located in the building at 20 Fenchurch St, London EC3M 3BY, the new offices will serve as a strategic hub for Appian to continue its growth in the UK, Europe, the Middle East, and Africa. The opening of the new Appian EMEA headquarters is part of the company's ongoing commitment to the region. The new office will provide a central location for a growing team of employees and experts in the UK, enabling them to collaborate more effectively with customers and partners across the region.

09:28 EDT Terreno Realty acquires industrial property in Washington D.C. for $13.4M - Terreno Realty acquired an industrial property located in Washington, D.C. on May 23 for a purchase price of approximately $13.4M. The property consists of one newly constructed industrial distribution building containing approximately 33,000 square feet on 1.3 acres.

09:27 EDT ClearPoint Neuro, UCB enter license agreement for gene therapy drug delivery - ClearPoint Neuro (CLPT) announced that it has entered into a multi-year license agreement with UCB (UCBJF) to partner on drug delivery platforms for UCB's gene therapy portfolio. Under the terms of the license agreement, UCB will utilize ClearPoint Neuro's proprietary technology and services in connection with the development and commercialization of UCB's gene therapy products. ClearPoint Neuro will receive success-based milestone payments. Further financial details of the agreement were not disclosed.

09:22 EDT STMicroelectronics appoints Nicolas Dufourcq as chairman of the board - Following the conclusion of the STMicroelectronics Annual General Meeting, which took place in Amsterdam, the members of the Supervisory Board appointed Mr. Nicolas Dufourcq as the Chairman and Mr. Maurizio Tamagnini as the Vice-Chairman of the Supervisory Board, respectively, for a 3-year term to expire at the end of the 2026 AGM.

09:17 EDT Upexi initiates development of AI engine for ad, marketing and logistics - Upexi announced its development of an artificial intelligence engine that will analyze current purchasing, advertising, customer buying habits, times, demographics and other data collected by the Company in partnership with SME Solutions Group. The data analyzed by the AI engine will be used to create real-time solutions for Upexi's advertising and marketing spends, allowing the Company to further maximize return on these expenses. The AI engine will analyze company data and data from various sources such as social media platforms, online shopping websites, and other sources to provide valuable insights into customer behavior patterns and preferences. This information will help Upexi make informed real-time decisions about its advertising and marketing strategies and spends.

09:14 EDT Pizza Inn unveils protoype buffet-style restaurant - Pizza Inn announced the debut of its new prototype buffet-style restaurant with the brand's return to the Asheboro, North Carolina, market. Elements of the new design combine modern simplicity and bold colors with warm woods and vintage themes.

09:13 EDT Nucor to cease production at Nucor Steel Longview - Nucor announced that it will reorganize the Company's plate group, including ceasing production at Nucor Steel Longview,. All Nucor Steel Longview teammates will be offered employment opportunities at other Nucor divisions. Purchased by Nucor in 2016 for approximately $29M, the mill produces heavy steel plate and has a rated annual capacity of 100,000 tons. The assets at Longview will be evaluated and deployed across Nucor's mills where appropriate. Nucor expects the phase out of production to occur in the Q3 of this year. Production will be transferred to Nucor's remaining plate mills, including its new state-of-the-art plate mill in Brandenburg, Kentucky, which began operating earlier this year. The Brandenburg mill will produce discrete, coiled, and heat-treated plate ranging from 60 to 168 inches wide, and in gauges from 3/16 of an inch to 14 inches.

09:10 EDT Sage Group announces series of updates for Sage Intacct - Sage announced a series of innovative updates to Sage Intacct to help businesses across the world simplify financial consolidations, streamline operations and improve financial planning.

09:09 EDT Sage Group announces update on development of connected accounting - Sage announced a major step forward in the development of connected accounting at its Partner Summit, LV23. The next evolution of Sage's digital network, known as Sage Network, seamlessly automates workflows between businesses regardless of whether they use Sage or non-Sage accounting software. Sage Network revolutionizes the way that businesses transact by connecting diverse accounting systems together to automate workflow between businesses. The advanced automation offered by Sage Network eliminates the need for manual data processing between companies, thereby enhancing data accessibility to support better decision-making regarding the use of working capital. Through strategic investments and partnerships fuelling its ongoing evolution, Sage Network will refine automated data flows, introduce innovative solutions, and cultivate enriched customer experiences. Sage Network is also a unique environment for the creation and deployment of ground-breaking applications, equipping third-party developers with universal APIs across various accounting software ecosystems. With access to the large market of Sage customers, as well as companies in the other accounting ecosystems, Sage Network creates opportunity for new and innovative solutions to enter the market.

09:07 EDT INmune Bio announces lecture at ISCT on INKmune - INmune Bio announces that Mark Lowdell, Ph.D., INmune Bio's CSO, will be giving the opening plenary lecture of the Presidential Symposium at the International Society of Cell and Gene Therapy, ISCT, in Paris, France on May 31st. Dr. Lowdell's lecture titled, "The Future of Immune Effector Cell Therapies for Cancer, Tumor-Primed Memory NK Cells - from Heresy to Clinical Trials," will describe how INKmune, INmune Bio's proprietary Natural Killer cell platform, primes the patient's NK cells to alter their phenotype to a cancer-killing population of memory-like NK cells that differ from single-cytokine or multiple-cytokine primed NK cells. The Company believes this is a critical breakthrough to avoid the complications associated with cytokine therapy and obtain NK cells ideally suited for attacking cancer. Dr. Lowdell's team at INmune Bio has shown that NK cells primed by INKmune or by the triple cytokine combination of IL12/15/18 consist of a complex mix of cell subsets with a unique memory associated phenotype. Using high-dimensional flow cytometry to simultaneously analyze 31 cell surface proteins, the team analyzed resting NK cells, IL-15 LAK, CIML-NK and INKmune-primed side-by-side. The data showed at least 8 clusters of NK cell types, one of which was restricted to CIML-NK and TpNK. This last cluster has never been described. "Whilst the existence of "memory-like" NK cells based on function has been known for over 10 years, it's safe to say no-one has identified a unique cell surface phenotype for these cells," said Dr. Lowdell. "Our interest in activating NK cells with INKmune to kill cancer provided a unique opportunity to better define these cells by comparison with CIML-NK."

09:05 EDT Chipotle announces partnership with Street Fighter 6 - Chipotle Mexican Grill announced its partnership with Street Fighter 6, the latest installment of one of the top selling fighting games of all time. Chipotle will be the first restaurant brand to give Street Fighter 6 players the opportunity to earn Fighter Coins through digital entree purchases made on the Chipotle app and Chipotle.com. Later this year, Street Fighter 6 will feature in-game integrations like Chipotle Daily Brackets, Battle Hub signage, and Chipotle-branded avatar items. In addition to the partnership with Street Fighter 6, Chipotle will serve as the presenting sponsor of the 2023 Evolution Championship Series, a sponsor of COMBO BREAKER, an advertiser on PlayStation media, and the first-ever restaurant brand to offer free food as viewer rewards on Twitch.

09:03 EDT Insperity announces 10% dividend increase to 57c per share - Insperity announced that its board of directors has approved a 10% increase in its quarterly regular cash dividend from 52c to 57c per share. The cash dividend will be paid on June 22 to all stockholders of record as of June 8.

09:03 EDT AbbVie announces presentation of data from RINVOQ studies - AbbVie announced that researchers will present new, long-term data supporting the efficacy and safety profile of RINVOQ, or upadacitinib, from the SELECT-COMPARE, SELECT-PsA 1 and SELECT-AXIS 2 studies at the European Congress of Rheumatology, EULAR 2023, taking place from 31 May - 3 June in Milan. Long-term data supporting the efficacy and safety profile of RINVOQ that will be presented at the EULAR 2023 Congress include more than 20 clinical endpoints and safety data from approximately 2,450 patients representing more than 6,700 patient-years across rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

09:02 EDT LPL Financial: Jonathan Kesselman joins broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisor Jonathan Kesselman CFP, has joined LPL Financial's broker-dealer, RIA and custodial platforms. He reported having served approximately $220 million in advisory, brokerage and retirement plan assets, and joins LPL from UBS. With the move, the Westlake, Ohio-based advisor is pleased to launch his new independent practice, Kesselman Wealth Management. He is joined by his wife, Rosie, who is the firm's director of business development and marketing.

09:02 EDT Intapp partners with BoardEx to accelerate business development efforts - Intapp announced a new partnership with BoardEx, an Altrata company, to help private capital, investment banking, legal, accounting, and consulting firms expand their market reach and win more business. Through this partnership, Intapp clients subscribing to BoardEx's global database of more than 1.7 million executives and board members can now directly access that data within DealCloud via an integration within DataCortex. New functionality will help users better ingest and take action on BoardEx data.

08:56 EDT Altamira Therapeutics reports data from Bentrio clinical study - Altamira Therapeutics announced statistically significant top-line results from the randomized controlled NASAR clinical trial evaluating its Bentrio nasal spray in patients with seasonal allergic rhinitis. Bentrio nasal spray is formulated as a drug-free and preservative-free gel emulsion designed to help protect against airborne allergens such as pollen or house dust mites. The NASAR trial enrolled 100 SAR patients in Australia who were randomized at a 1:1 ratio to receive either Bentrio or saline nasal spray for two weeks via self-administration three times per day, or as needed. For eligibility, patients had to have a baseline reflective Total Nasal Symptom Score of at least 5 points out of 12, referring to the worst level of nasal congestion, sneezing, nasal itching, and rhinorrhea within the past 24 hours averaged over a one-week treatment-free run-in period. The primary efficacy endpoint was defined as the difference in the average rTNSS over the subsequent 2-week treatment period between Bentrio and saline nasal spray, the current standard of care in drug-free SAR management. The change in mean rTNSS over two weeks is generally accepted as a primary efficacy endpoint for SAR trials and is also recommended by the FDA. The rTNSS decreased in the Bentrio group from 6.9 points in the pre-treatment period to an average of 5.0 points over the 14-day treatment period, while the saline spray group showed a decrease from 6.9 to 6.2 points. The reduction in nasal symptoms conferred by Bentrio was thus 2.5 times larger than with saline nasal spray. The difference in rTNSS reduction of 1.1 points in favor of Bentrio was statistically significant in the ANCOVA model, and the study thus met the primary efficacy endpoint. The treatment effect shown with Bentrio was well above the minimal clinically important difference of 0.28 points. 63.3% of Bentrio-treated study participants rated treatment efficacy as either good or very good vs. 29.2% of saline-treated participants. Among the latter, 45.8% reported efficacy as poor vs. only 8.2% in the Bentrio group. 73.5% of Bentrio-treated study participants rated tolerability of the treatment as either good or very good vs. 85.5% of saline-treated participants. Among the latter, 10.4% reported tolerability as poor vs. only 6.1% in the Bentrio group.

08:53 EDT Pearson, CAE partner for critical thinking assessment in secondary education - Council for Aid to Education announced the immediate availability of its College and Career Readiness Assessment through a non-exclusive partnership with Pearson. Pearson will resell CCRA+ as part of its Pearson Assessment for Learning Suite. Designed for students in grades six through 12, CCRA+ assesses critical thinking, problem solving and written communications - essential skills that are predictive of positive academic and career success. These skills are highlighted in Portraits of a Graduate profiles, yet most states and districts do not have an effective and reliable approach to measure these skills.

08:49 EDT Rubicon Technologies enters pact with GoldOller Real Estate Investments - Rubicon Technologies announced that it has entered into an agreement with GoldOller Real Estate Investments, a seasoned real estate investment and management firm, to provide scalable waste and recycling services.

08:48 EDT Smart for Life launches line of Sports Illustrated protein bars - Smart for Life is launching a new line of Sports Illustrated protein bars, specifically formulated for active lifestyles. The premium line of protein-based bars are formulated to address a growing demand for clean and nutritional products that match the needs of athletes and health-conscious consumers alike. The new line of protein bars is clean and energizing, non-GMO, cold-pressed, with no sucralose and no preservatives, and includes some options that are gluten-free. Launch flavors include Triple Chocolate, Cookies & Cream, Blueberry White Chocolate and Strawberry Chocolate. The bars are expected to be released in select markets for initial testing in Q3 of 2023 with select preorders available for certain flavors online.

08:46 EDT Stryker: EPS cases utilizing its Q guidance system 'are underway' - Stryker announced that Early Product Surveillance or EPS, cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries. Stryker's Q Guidance System with Cranial Guidance Software provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries. "In my opinion, Stryker's Q Guidance System with Cranial Guidance Software could be the new gold standard for image-guided neurosurgical navigation," said Dr. Melvin Field, medical director for the Minimally Invasive Brain Surgery program at AdventHealth, and member of Orlando Neurosurgery, one of the first surgeons to bring the system to his OR. "Cranial procedures are extremely delicate, and outcomes may go beyond physical health, potentially altering your patient's appearance or personality. The system offers advanced planning and guidance capabilities, giving me greater confidence to perform these complex surgeries." Leading up to a full commercial launch, Stryker's Q Guidance System with Cranial Guidance Software will be utilized at five additional EPS sites: the University of New Mexico, the University of Arkansas, the University of Michigan, Thomas Jefferson University, and Lenox Hill Hospital. Cranial Guidance Software provides a single solution to track brain biopsy and shunt placement instruments, and includes automatic, algorithmic processing as well as comprehensive segmentation capabilities. The software provides tools enabled by gesture recognition for identifying, marking, and localizing targets and anatomical structures of interest. .

08:42 EDT BlackSky, Spire Global team on commercial MCS for flexible vessel tracking - BlackSky Technology Inc. (BKSY) and Spire Global (SPIR) have teamed up to create a real-time, commercially available Maritime Custody Service, MCS, that can automatically detect, identify and track more than 270 thousand vessels worldwide in open water, along rivers and canals, and while docked at port. "BlackSky and Spire have developed a very cost-effective and flexible vessel tracking service capable of delivering on-demand maritime intelligence at scale," said Patrick O'Neil, chief innovation officer at BlackSky. "The unique AI-driven system reduces end-to-end latency across the entire tasking, collection, processing, exploitation, and dissemination process. With interoperability in mind, the MCS provides an easy-to-use autonomous, continuous and predictive maritime tracking capability directly into customer hands." The MCS uses data from Spire's satellites to detect RF emissions from maritime targets and then automatically tips BlackSky's satellites to collect imagery. Once collected, BlackSky Spectra AI processes and analyzes the electro-optical images using artificial intelligence to detect vessels, estimate cargo, and monitor change over time. Monitoring global maritime activity is critical to safeguarding national security, identifying illicit ship-to-ship transfers, intercepting vessels engaged in smuggling or sanctions evasion, monitoring liquid and dry bulk commodity movements, and tracking illegal fishing in restricted areas.

08:40 EDT Inuvo announces AI-based Media Mix Modeling solution - Inuvo launched a Media Mix Modeling technology as part of its IntentKey suite of AI solutions. The IntentKey can now predict, based on historical spend and performance, the optimal mix of media for any given budget, across channels, without using consumer tracking IDs. Inuvo's solution has been in beta for almost 24 months and is now available to clients and prospects. Richard Howe, CEO of Inuvo, stated, "As the ability to identify and track consumers becomes increasingly difficult, the two biggest challenges for marketers are: how to find and target audiences and how to confidently determine budget across media channels. Inuvo's generative IntentKey AI has solved the first of these challenges and has now been complemented by machine learning technology to solve the second." Howe continued, "As the number of marketing channels increases, so does the challenge of effectively capitalizing on advertising supply and demand economics across those channels. Marketers need to know how to predictively turn the spend amounts up or down, in any given period, across all the channels they use. This reality is further complicated by each channels' motivation to overweight its own contribution to the consumers conversion."

08:39 EDT Camber Energy, Viking Energy file amended S-4 regarding proposed merger - Camber Energy and Viking Energy Group announced that Camber filed on May 23, 2023, an amendment to its previously filed registration statement on Form S-4 with the U.S. Securities and Exchange Commission regarding the merger of Camber and Viking. Although the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about the proposed transaction which contemplates a wholly owned subsidiary of Camber merging with and into Viking, with Viking surviving the Merger as a wholly-owned subsidiary of Camber and Camber remaining the sole publicly-traded entity. Completion of the transaction is subject to shareholder approval, the Registration Statement being declared effective by the SEC, and other customary closing conditions.

08:36 EDT Bridgeline Digital's Hawksearch selected by Aaron Equipment - Bridgeline Digital announced that Aaron Equipment chose its AI-powered site search solution, HawkSearch, to provide site search, recommendations, and data quality enhancement for their B2B ecommerce site. Aaron Equipment Company has selected Bridgeline's HawkSearch to drive personalized recommendations and smart search capabilities. HawkSearch will power site search functionality for Aaron Equipment's range of products and services, including asset management, equipment financing and appraisal, listing for sale, auction and plant closing services. HawkSearch has served other leaders within the B2B industry, such as Berlin Packaging, Kirby Risk, and Packard.

08:35 EDT Citi to pursue IPO of Banco Nacional de Mexico business - Citi announced it will pursue an initial public offering, or IPO, of its consumer, small business and middle-market banking operations in Mexico following the planned separation of its leading institutional business that will remain part of Citi. As previously disclosed, Citi had been pursuing a dual process to exit the business, including preparation for a possible IPO. The business will retain the Banco Nacional de Mexico brand. Banamex will continue offering a full suite of financial services to consumers and small and mid-market business owners through an distribution network of 1,300 branches, 9,000 ATMs, 12.7 million retail banking clients, 6,600 commercial banking clients and ~10 million pension fund customers.

08:35 EDT Lincoln will be added to preliminary list of reconstituted Russell 3000 Index - Lincoln Educational Services Corporation has been included in the preliminary list of additions to the annual reconstitution of the broad-market Russell 3000 Index. The list including Lincoln was posted to the FTSE Russell website following the close of the U.S. markets on May 19, 2023. The annual reconstitution is effective as of the U.S. market open on June 26, 2023.

08:34 EDT Citi to pursue IPO of Mexico business Banamex

08:33 EDT Eterna appoints Yung as Chief Strategy Officer, General Counsel - Eterna Therapeutics (ERNA) announced the appointment of Megan Yung as Chief Strategy Officer and General Counsel. Yung will work with Eterna's senior leadership and the Board of Directors to develop and advance the Company's corporate strategy. Yung will also oversee the company's legal activities, including licensing and intellectual property matters. Yung joins Eterna from SQZ Biotechnologies (SQZ), where she served as Deputy General Counsel and Vice President, Head of Intellectual Property, and helped oversee matters of intellectual property, regulatory compliance, public company reporting, business development activities and negotiations, and government affairs.

08:27 EDT Polaris Renewable Energy signs 25 MW power purchase agreement - Polaris Renewable Energy signed a Power Purchase Agreement in the Dominican Republic for Canoa II. The Canoa II solar project is adjacent to the already operational 25MW Canoa I, which was acquired by the Company in July of 2022, and is inthe Province of Canoa, Municipality of Barahona, Dominican Republic. Polaris owns 100% of the project.Particulars related to the Canoa II PPA and project are: 15-year PPA denominated in US$ of $82.35 per MWh; Such PPA has an annual inflator for 5 years post initial commencement, equivalent to approximately 16% of the US Consumer Price Index, at which point the price remains fixed until the end of the 15-year term; Estimated completion of construction in the third quarter of 2024.

08:21 EDT Advantage Solutions names Macedonio to its board of directors - Advantage Solutions has appointed Jody Macedonio, chief financial officer for Meati, maker of animal-free meat alternatives, to its board of directors. Prior to joining Meati as the company's top finance executive in 2022, Macedonio served as chief financial officer of Chobani.

08:20 EDT AGF Management appoints Ken Tsang as CFO - AGF Management announced the appointment of industry veteran Ken Tsang to the position of CFO. Ken will join the organization on June 1, reporting to Kevin McCreadie, CEO and Chief Investment Officer, AGF. He was most recently the CFO, Head of Strategy & Business Development at Capital One Canada. Jenny Quinn will remain at AGF and will be returning to her role as Chief Accounting Officer. She will work closely with Ken on the CFO transition.

08:18 EDT Sarepta: FDA working towards accelerated approval for SRP-9001 for DMD treatment - Sarepta Therapeutics provided the following update on the Biologics License Application for SRP-9001, or delandistrogene moxeparvovec, which is currently under review for the treatment of ambulant individuals with Duchenne muscular dystrophy or DMD, who have a confirmed mutation of the DMD gene. Following discussions with FDA, the Agency has indicated that, subject to the completion of the BLA review, it is working toward potentially granting an accelerated approval for SRP-9001, initially for use in Duchenne patients ages 4-5 years old. EMBARK, the global, randomized, double-blind, placebo-controlled Phase 3 trial of SRP-9001, is the proposed confirmatory study. The Agency has informed Sarepta that, in addition to confirming the results of the initial BLA approval, if the trial meets its objectives the Agency intends to entertain a non-age-restricted expansion of the SRP-9001 label based upon the review of the EMBARK data. EMBARK is fully enrolled, with top-line results expected in the fourth quarter of 2023. The FDA has also informed Sarepta that it requires modest additional time to complete the review, including final label negotiations and post marketing commitment discussions, and that it anticipates that the review will be complete by June 22 . Sarepta will remain in a quiet period for the duration of the BLA review.

08:18 EDT Applied Digital, Super Micro Computer partner for AI cloud services - Applied Digital Corporation (APLD) announced that the Company is working with Supermicro (SMCI) to deliver Applied Digital's AI Cloud service. "We are in the middle of the most dynamic industry changes seen in decades, and it's exciting to be collaborating with a recognized industry leader like Supermicro to leverage their HPC expertise and support in the next wave of AI-powered applications," said Wes Cummins, CEO and Chairman of Applied Digital.

08:15 EDT Rani Therapeutics appoints McKinley as Chief Business Officer - Rani Therapeutics announced that it has appointed Kate McKinley as its Chief Business Officer, CBO. Prior to joining Rani, McKinley was the Founder and Chief Executive Officer of Spark Outcomes, where she served as a fractional executive and corporate adviser for early-stage pharmaceutical, diagnostics, and health tech start-ups.

08:13 EDT PTC director sells $5.38M in common stock - In a regulatory filing, PTC disclosed that its director Blake Moret sold 40K shares of common stock on May 22nd in a total transaction size of $5.38M.

08:13 EDT Maris-Tech enters into agreement with major distributor in Turkey - Maris-Tech announced that it has entered into an agreement with IMCA Elektronik in Turkey, IMCA, a major distributor of products for defense, aviation, transportation, industrial and consumer electronics applications in Turkey. Pursuant to the agreement, Maris-Tech appointed IMCA as the Company's exclusive distributor in Turkey, and as such IMCA will promote and sell Maris-Tech products. "We are honored to have IMCA as our exclusive distributor in Turkey, promoting the sale of Maris-Tech's cutting edge and unique products in new territory with one of the most advanced defense industries in the world. Cooperation with IMCA, an established and experienced distributor, enables us to continue our international expansion with entry into Turkey's large and important market," said Israel Bar, CEO of Maris Tech.

08:12 EDT U Power received notification of non-compliance from Nasdaq - U Power Limited announced that it received a notice of non-compliance from Nasdaq Stock Market on May 19, 2023, stating that, as a result of not timely filing its annual report on Form 20-F for the year ended December 31, 2022, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the U.S. Securities and Exchange Commission. This notice has no immediate effect on the listing or trading of the Company's ordinary shares on the Nasdaq.

08:09 EDT Southern California announces retirement of CCO Williams, Nutz to succeed - Southern California Bancorp announces that Anne Williams, Chief Credit Officer, CCO, of the Bank, will retire effective as of May 31, 2023. She will be succeeded as Chief Credit Officer by Peter Nutz, currently Executive Vice President, Credit Administrator of the Bank. Williams will remain as a member of the Board of Directors of each of the Company and the Bank. Prior to joining the Bank, Nutz was Executive Vice President, Chief Credit Officer at Suncrest Bank.

08:09 EDT Canacol Energy tests 22 MMSCFPD from Lulo 1 - Canacol Energy provides the following information concerning the new Lulo 1 gas discovery and near term drilling plans. Lulo 1 tests 22 MMscfpd: As announced on May 3, 2023, the Lulo 1 exploration well, located on the 100 percent operated VIM21 Exploration and Production contract, encountered 207 feet of net gas pay within the Cienaga de Oro sandstone reservoir. Lulo 1 was permanently tied in and production tested through the Jobo gas processing facilities located 50 meters away at an average rate of approximately 17 million standard cubic feet per day for 7 days. The well was tested at various rates ranging from 3.9 MMscfpd to 22.2 MMscfpd with the choke varying between 19/128 and 39/128 inches and a final tubing head pressure of 2,042 psi at the rate of 22.2 MMscfpd, and is currently producing at a controlled rate of approximately 17 MMscfpd. Lulo 2 drilling ahead: The Corporation commenced drilling of the Lulo 2 appraisal well on May 17, 2023, with the well anticipated to be completed and placed on production by the end of May 2023. It is anticipated that should Lulo 2 prove successful, the Lulo discovery, announced on May 3, 2023, will be capable of producing at a total rate of between 30 and 40 MMscfpd by early June 2023. Near term exploration plans: Upon completion of the Lulo 2 well, the Corporation will mobilize the rig to commence drilling of the Pina Norte 1 exploration well, located approximately 300 meters to the southwest of the Jobo production facility. The Pina Norte prospect, like Lulo, is one of 5 exploration prospects identified within the middle to lower CDO sandstone reservoir within very close proximity to the Corporations main production facilities at Jobo. If successful, as is the case for Lulo, these near field exploration prospects can each provide new commercial production within weeks of discovery. The Corporation expects results from Pina Norte 1 by mid July, 2023, following which the Corporation plans to drill the Cereza 1 exploration well located approximately 1 kilometer to the north of the Jobo production facility. Canacol's near term drilling focus is to increase productive capacity ahead of the upcoming El Nino season to ensure the adequate supply of natural gas to the Caribbean market.

08:07 EDT Pliant Therapeutics presents data from its bexotegrast program - Pliant Therapeutics announced that it presented Phase 2a clinical data and preclinical data of bexotegrast this week as part of the American Thoracic Society, ATS, 2023 International Conference, held from May 19 through May 24, 2023. PLN-74809 Shows Favorable Safety and Tolerability and Indicates Antifibrotic Activity in a Phase 2a Study for the Treatment of Idiopathic Pulmonary Fibrosis. In an oral presentation, Lisa Lancaster, M.D., Professor of Medicine at Vanderbilt University Medical Center and principal investigator of the INTEGRIS-IPF Phase 2a trial, reviewed 12-week data from the trial. Results showed that bexotegrast was well tolerated across all four dose groups with bexotegrast-treated participants experiencing a reduction in forced vital capacity decline over 12 weeks versus placebo, on and off background therapy. A dose-dependent downwards trend was observed in the proportion of participants with forced vital capacity precent predicted decline greater than or equal to10%, a well-established predictor of death and disease progression in IPF. Combining Dual alphaVbeta6/alphaVbeta1 Integrin Inhibitor, PLN-74809, With Standard-of-Care Therapies Has a Synergistic Effect on Reducing Fibrogenic Gene Expression in Fibrotic Human Lung Slices. Fibrotic human precision-cut lung slices were cultured to investigate the individual and combined effects of bexotegrast and nintedanib or pirfenidone on the expression of genes related to the pathogenesis of idiopathic pulmonary fibrosis. Results from a differential gene expression analysis suggest the mechanism of action of bexotegrast may be both independent of, and complementary to, that of currently approved therapies. Dual alphaVbeta6/alphaVbeta1 Integrin Inhibitor PLN-74809 Attenuates Pathologic Fibroblasts in Human Fibrotic Lung Explant Tissue. Bexotegrast demonstrated reductions in pro-fibrotic gene expression within unique cell populations including on a number of CTHRC1-high expressing fibroblasts, pro-fibrotic genes, including COL1A1 and VIM, and in alphaVbeta6-expressing aberrant basaloid cells that reside adjacent to areas of acute lung injury. Results also demonstrated the utility of combining single cell transcriptomic techniques with fibrotic human tissue to evaluate the mechanism of action of novel anti-fibrotic therapies, such as bexotegrast.

08:05 EDT Eloxx Pharmaceuticals intends to advance ELX-02 into trial - Eloxx Pharmaceuticals announced that the company intends to advance ELX-02 into a pivotal trial for the treatment of Alport syndrome with nonsense mutations, following the achievement of remission in one patient in its Phase 2 clinical study. The patient demonstrated a significant reduction in urine protein creatinine ratio, UPCR, from baseline. Consistent with prior clinical studies, ELX-02 was well tolerated in this trial. Topline Results of ELX-02 Phase 2 Trial for Alport Syndrome : Eloxx has dosed three patients with ELX-02 in the ongoing proof-of-concept Phase 2 open-label clinical trial. Two patients have now completed dosing and the third patient is still receiving ELX-02. One patient that has completed dosing achieved a remission, defined as a UPCR decline greater than or equal to 50%. For this patient, five out of eight UPCR readings produced an average of 53% below baseline. Spontaneous reductions in proteinuria are not expected in this population, providing added weight to this result. The patient achieving remission also demonstrated a significant reduction in UPCR from baseline versus values collected over the treatment period. The UPCR value for week 6 was excluded from this analysis as it was deemed to be unreliable due to delayed processing over a holiday period, potentially resulting in protein degradation and inaccurate proteinuria readings. No significant change in UPCR was seen in the other patient that has completed 8 weeks of dosing. Both patients had the same Col4A4 mutation, but were being treated with substantially different levels of renin-angiotensin-aldosterone system inhibitors. Assessment of COL IV protein restoration remains ongoing as both patients had Col4A4 mutations and the kidney biopsy assay was designed to assess COL IVA5 protein expression. Consistent with previous clinical studies, ELX-02 has been generally well tolerated with no discontinuations to date. Kidney biopsies from both patients after 8 weeks of dosing demonstrated no evidence of nephrotoxicity, further demonstrating tolerability.

08:04 EDT 4D Molecular presents interim data from 4D-710 Phase 1/2 AEROW trial - 4D Molecular Therapeutics announced an oral presentation of the interim data from the 4D-710 Phase 1/2 AEROW clinical trial for the treatment of cystic fibrosis lung disease at the European Cystic Fibrosis Society 46th Annual Meeting held in Vienna, Austria on June 7-10, 2023. 4D-710 is comprised of our targeted and evolved vector, A101, and a codon-optimized CFTRR transgene and is designed for aerosol delivery to achieve CFTR expression within lung airway epithelial cells. 4D-710 is being initially developed in the approximately 15% of patients whose disease is not amenable to existing CFTR modulator medicines targeting the CFTR protein. The oral presentation will be given by Jennifer Taylor-Cousar and will include clinical and biomarker data for Cohort 1 patients. Clinical data will focus on safety, tolerability, pulmonary function testing and respiratory-related quality of life assessments. The presentation will also include biomarker data on expression of the cystic fibrosis transmembrane regulator transgene protein from the endobronchial lung biopsies & brushings collected at week 4-8 after dosing.

08:02 EDT Azenta announces collaboration with Lupus Research Alliance - Azenta announced it has been selected by the Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to support the development of the patient registry component of the Lupus Nexus, which aims to advance and accelerate lupus research and drug discovery through information exchange capabilities. Azenta will serve as the exclusive sample management services provider including collection kit design, lab services, logistics, and biorepository storage for this transformational project.

07:58 EDT Nikola encourages stockholders to vote for Proposal 2 - Nikola encourages all stockholders to vote now for Proposal 2, which would allow Nikola to increase its authorized number of shares of common stock. Approval of this proposal will help ensure that Nikola can continue moving forward to achieve new milestones on the path to pioneering solutions for a zero-emissions world. Without these additional shares, Nikola's ability to continue its ongoing operations and objectives, including Nikola's need for capital, will be out of reach. Stockholders as of the close of business on April 10, 2023, are entitled to vote, even if they no longer own the shares.

07:54 EDT Asante Gold provides update on discussions with Fujairah - Asante Gold provides the following update regarding the previously disclosed, unsolicited, non-binding expression of interest from Fujairah Holding to acquire all of the Company's issued and outstanding common shares not held by Fujairah. Fujairah requested a 30 day extension to its exclusivity agreement with Asante, which has been in effect from May 8. Fujairah has advised that its technical due diligence process has been delayed due to inability of their consultants to conduct their site visit and complete this part of its due diligence process. While the Board welcomes the Fujairah offer, there are other financial opportunities of interest and Asante believes that another extension is not in the best interests of the Company. Asante will continue discussions related to other financial opportunities, while supporting the Fujairah due diligence process. Should a formal offer from Fujairah materialize, the Board would welcome this. The Board is committed to maximizing value for all shareholders and recognizes the offer price of C$2.20 per share is very low. It believes that granting further exclusivity to any one party for an extended period is not in the best interests of the process. On May 16, 2023, Asante announced that it had extended Fujairah's exclusivity until 5:00 p.m. on May 19, 2023 to provide additional time for Fujairah to complete its due diligence review. Although the Company has declined to extend Fujairah's exclusivity it continues to work with Fujairah to support completion of its due diligence review in connection with the Non-Binding Expression of Interest and a potential financing transaction.

07:40 EDT Nextech3D.ai announces trade date of June 13 for Toggle3D.ai - Nextech3D.AI announces the eagerly anticipated spin-off of Toggle3D.ai. The expected trade date for Toggle3D.ai is June 13, 2023 of the Canadian Securities Exchange. Nextech shareholders of record will be issued an exclusive dividend of 4,000,000 newly issued shares in the revolutionary Toggle3D.ai, on a pro-rata basis.

07:38 EDT Pipestone to increase production volumes at Grande Prairie over coming days - Pipestone Energy Corp. provides an update to the Alberta wildfire impact on its Grande Prairie area operations. The company said, "As previously announced, approximately 20,000 boe/d of production was temporarily curtailed as a result of the precautionary shut-in of certain third-party infrastructure and associated operated producing locations on the evening of May 12, 2023. As a result of the outstanding efforts of local fire authorities and favorable weather conditions in the last few days, the fires that have been impacting a number of our third-party infrastructure and associated producing locations are now under control. We expect to increase production volumes over the coming days back to full productive capacity. The Company is not aware of any significant damage or loss to either its owned or third-party infrastructure and we would like to sincerely thank all of our staff, third-party infrastructure partners, local fire authorities and all those involved for their continued efforts in managing the ongoing wildfire situation."

07:38 EDT OptimizeRx CEO provides 2023 midyear strategic update - OptimizeRx provides a 2023 mid-year strategic update commenting on: current revenue backlog, strategic roadmap with key pillars of growth, and long term financial performance aspirations through steady buildout of scalable, future proofed, enterprise solution suite. "Although we reported our financial earnings recently, I wanted to share in more detail what has me excited about our prospects... Midyear revenue backlog. Today, our mission and passion continue to power drug maker brand awareness with prescribing physicians through patient treatment initiation, affordability and adherence. These efforts are packaged in a comprehensive, best-in-class enterprise solutions suite. Having finished the first quarter of 2023 achieving $13 million in revenues, which was at the high end of revenue guidance, we are confident in our operational and financial visibility...Integrated engagement approach for all stakeholders. In spite of prolonged challenges with the macro-environment, coupled with the short-term noise of disengaged, standalone offerings from new competitors, we continue to future proof OptimizeRx's utility to customers. Driving this dynamic is our machine learning based approach to integrated engagement at point-of-care and beyond... Innovation and smart acquisitions currently driving growth. We spent two years developing our RWD.AI platform to extend engagement points with the same pool of prescribers outside the EHR and into care-adjacent digital settings such as social media where we have access to over 2 million HCP profiles and 90% of the nation's health system intranet/websites. Since acquiring EvinceMed, that gave us a modular automation architecture, purpose-built for specialty therapies, we have continued to stay ahead of the industry curve with innovations that have enhanced our smart, data-driven technology offerings, which now includes web display."

07:36 EDT Ituran approves distribution of 15c per share cash dividend - Ituran Location and Control announced that the Board of Directors approved the distribution of a cash dividend in the amount of 15c per share, totaling approximately $3M. The dividend will be paid to shareholders of record as of June 28. The company will pay the dividend out on July 12, net of taxes at the rate of 25%.

07:35 EDT Endo announces distribution agreement with MAIA Pharmaceuticals - Endo International announced that its subsidiary, Endo Ventures Limited, has executed an agreement with MAIA Pharmaceuticals to distribute bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial in the U.S. Endo will commercialize the FDA-approved product through its Par Sterile Products business and expects to begin shipping in summer 2023.

07:33 EDT Dragonfly Energy lithium batteries to be installed on new leisure travel vans - Dragonfly Energy has partnered with Triple E Recreational Vehicles to include Dragonfly Energy's lithium-ion batteries as standard equipment on all Leisure Travel Vans, a brand of Triple E RV, starting with the 2024 model year. Each 2024 Leisure Travel Van will include two Dragonfly Energy 12v 100Ah LiFePO4 batteries per unit, providing enough power for day-to-day usage without having to be connected to a power source. "Triple E RV was among Dragonfly Energy's first Original Equipment Manufacturers to offer lithium batteries as an option to the RV market," Wade Seaburg, Chief Revenue Officer for Dragonfly Energy, said. "We believe the conversion to lithium is undeniable and making our lithium-ion batteries standard on Triple E RV's Leisure Travel Vans is a big win for customers. We look forward to further partnerships with Triple E RV on their lithium journey."

07:23 EDT Analog Devices: Longer term focus for data processing shifting 'to the edge' - "Longer term, the center of gravity for data processing is shifting from the cloud to the edge, thanks to emerging applications that include Industry 4.0, Smart Energy Systems, Electric Vehicles, Advanced Connectivity, and Immersive Consumer. ADI's alignment with these applications, where semiconductor content per dollar of capex is increasing, presents tremendous growth opportunities. I am excited for what our future holds as we continue to deliver breakthrough solutions at the Intelligent Edge for our customers," said Analog Devices management.

07:21 EDT Mosaic announces $700M term loan facility - The Mosaic Company closed on a new $700M 10-year term loan facility through the Farm Credit System. Uniquely available to agribusiness participants, this facility provides attractive terms that include a delayed draw option and prepayment with no penalty. The initial interest rate under the agreement is 175 basis points over the Secured Overnight Financing Rate.

07:19 EDT Analog Devices sees 2H revenue to moderate amid 'continued economic uncertainty' - "ADI continued to execute well in the second quarter with revenue growth for the thirteenth consecutive quarter and record earnings per share," said Vincent Roche, CEO and Chair. "Looking to the second half, we expect revenue to moderate given the continued economic uncertainty and normalizing supply chains. However, I am confident in ADI's ability to navigate short-term business cycles due to the strength and diversity of our franchise, our hybrid manufacturing model, and alignment to secular growth trends."

07:13 EDT PacWest sells Civic Financial Services unit to Roc360; terms not disclosed - Roc Capital Holdings on Tuesday announced it has purchased the origination assets of Civic Financial Services, a subsidiary of Pacific Western Bank. Under the terms of the transaction, CIVIC sold its origination assets to Roc360. Excluded from the sale are previously originated, loans and loan servicing operations. Roc360 will use the storied and trusted brand name CIVIC, which will join Roc360's growing portfolio of real estate brands, including Roc Capital, Finance of America Commercial, ElmSure, Wimba Title, and Tamarisk Appraisals. Piper Sandler and Company served as financial advisor to PacWest Bancorp in the transaction.

07:11 EDT Timbercreek Financial announces normal course issuer bid - Timbercreek Financial announced that it has obtained the approval of the Toronto Stock Exchange to commence a normal course issuer bid with respect to its common shares. The NCIB will commence on May 26, 2023 and will terminate on the earlier of May 25, 2024 or the date on which the Company has purchased the maximum number of Shares permitted under the NCIB. Under the NCIB, the Company may, over a 12-month period commencing on May 26, 2023, purchase in the normal course through the facilities of the TSX in accordance with its rules or through alternative Canadian trading platforms up to a regulatory maximum of 8,305,467 Shares, such amount representing 10% of the public float of the Shares issued and outstanding as of May 15, 2023. Furthermore, subject to certain exemptions for block purchases, the maximum number of Shares that the Company may acquire on any one trading day is 30,248 Shares, such amount representing 25% of the average daily trading volume of the Shares for the six calendar months prior to the start of the NCIB, being 120,994 Shares. As of May 15, 2023, there were 83,775,016 Shares issued and outstanding. Under the normal course issuer bid which commenced on May 26, 2022 and terminates on May 25, 2023, the Company was authorized to purchase up to 8,330,591 Shares and purchased 230,000 Shares on the open market at a volume weighted average price of $7.35 per Share. Purchases made under the 2022 NCIB were made either through the facilities of the TSX in accordance with its rules or through alternative Canadian trading platforms. All Shares purchased under the 2022 NCIB by the Company were cancelled. The price which the Company will pay for any Shares under the NCIB will be the market price at the time of acquisition. During the period of the NCIB, the Company may make purchases under the NCIB by means of open market transactions or otherwise as permitted by the TSX. All purchases under the NCIB will be purchased on the open market through the facilities of the TSX and alternative Canadian trading platforms at the prevailing market price at the time of such transaction. Any Shares purchased by the Company will be cancelled. National Bank Financial will conduct the bid on behalf of the Company. The Company believes that the market price of its Shares may not, from time to time, accurately reflect their underlying value, making the purchase of Shares an attractive investment and an advantageous use of the Company's available funds. The Company expects that the purchase of Shares will benefit remaining shareholders by increasing their equity interest in the Company's assets.

07:11 EDT KKR Real Estate Select Trust names Julia Butler CIO - KKR announced that the Board of Directors of KKR Real Estate Select Trust has appointed Julia Butler to the newly created role of Chief Investment Officer of KREST. A veteran real estate investor and Managing Director at KKR, Ms. Butler is now on KREST's dedicated senior leadership team. She will oversee investment management for the Fund as it continues to scale its high-quality global portfolio of private real estate equity and credit investments and seeks to capitalize on opportunities in the current environment to create long-term value for investors. "We have built KREST to provide individual investors access to the full breadth of KKR's global real estate platform with a dynamic investment strategy designed to deliver attractive yield and long-term performance across different macroeconomic environments," said Ralph Rosenberg, Chairman of KREST and Global Head of KKR Real Estate. "We are committed to building a best-in-class management platform as KREST continues to scale. Julia is a senior leader of our real estate business with two decades of experience investing across the real estate capital structure as both an equity and credit investor. She has played an integral role in scaling KKR's real estate business to over $65 billion in assets under management and she will be a key contributor to the continued commercial success of KREST."

07:10 EDT Evogene's Lavie Bio receives registration for Thrivus from CFIA - Lavie Bio, a subsidiary of Evogene, announced it had received registration for Thrivus from The Canadian Food Inspection Agency, which triples the product's sales territory. Thrivus, a bio-inoculant seed treatment, increases Hard Red Spring Wheat production by increasing the availability and efficiency of soil nutrients while mitigating environmental stresses and improving production in sub-optimal areas of farmers' fields.

07:09 EDT Gray Television promotes Moran to Senior Managing Vice President - Gray Television announced the promotion of Matt Moran to Senior Managing Vice President, through which he will oversee a group of Gray's television markets in the Midwest, effective immediately. Matt has served as the General Manager of WOIO, WUAB and WTCL in Cleveland, Ohio, since December 2021 and as a Regional Vice President overseeing Gray's television stations in Binghamton and Watertown, New York, since August 2022.

07:08 EDT Xortx announces 180-day extension to regain compliance with minimum bid price - XORTX Therapeutics announces that on May 23, 2023 it received a notice from the Nasdaq Stock Market granting the Company's request for a 180-day extension to regain compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Rule 5550(a)(2). The Company was first notified by Nasdaq of its failure to comply with the Minimum Bid Requirement on November 22, 2022, and was given until May 22, 2023 to regain compliance. The Company now has until November 20, 2023 to meet the requirement.

07:06 EDT Renren announces repurchase of SoftBank Group shares - Renren (RENN) announced the repurchase of 288M ordinary shares of the company held by SoftBank Group Capital (SFTBY). On May 23, 2023, Renren entered into a share repurchase agreement with SoftBank, under which the company repurchased from SoftBank 152,870,520 Class A ordinary shares and 135,129,480 Class B ordinary shares of the company at an aggregate purchase price of $7,132,160, which is equivalent to $1.1144 per ADS. The company used cash on hand to complete the share repurchase and retired the ordinary shares purchased. The share repurchase was made under the company's current share repurchase program as previously approved by the board of directors of the company. Following the share repurchase, approximately $1.1M remains authorized and available for further repurchases, as conditions allow, on the open market or through privately negotiated transactions.

07:03 EDT Children's Place plans to close 80-100 stores in 2023 - The Company ended the first quarter of 2023 with 599 stores and square footage of 2.9 million, a decrease of 9% compared to the prior year. Consistent with the Company's store fleet optimization initiative, the Company permanently closed 14 stores during the first quarter of 2023 and has permanently closed 600 stores since 2013 and decreased total square footage by 2.4 million square feet or approximately 45%. The Company is planning to close a total of approximately 80 - 100 stores this year.

06:59 EDT PPG sees annual adjusted EPS growth 8%-12% through 2026 - The company shared details of its organic growth framework and expectations: established annual 2%-4% organic sales growth; annual adjusted EPS growth of 8% to 12% through 2026; and free cash flow of approximately $1B per year. "PPG is poised to leverage our diverse business portfolio to deliver industry-leading growth," said CEO Tim Knavish. "Going forward, we will intentionally invest in focused growth opportunities that enhance our customers' productivity and sustainability, elevate our customer relationships and expand PPG's technology leadership positions in the coatings industry. We will continue our heritage of cost management, consistent cash generation and focus on returning cash to shareholders, including through increased annual dividends." Knavish added, "Solutions that generate productivity and sustainability benefits for our valued customers are a key piece of our growth strategy. We've made strong progress against our 2025 sustainability goals and now are pleased to introduce ambitious 2030 Environmental, Social and Governance targets, including a sales target for sustainably advantaged products and greenhouse gas emissions reduction targets validated by the SBTi."

06:49 EDT Spire Global and BlackSky develop Maritime Custody Service - Spire Global (SPIR) and BlackSky (BKSY) have developed a real-time, commercially available Maritime Custody Service, or MCS, that can automatically detect, identify and track more than 270,000 vessels worldwide in open water, along rivers and canals, and while docked at port. The MCS uses data from Spire's radio frequency-monitoring satellite constellation to detect emissions from maritime targets, including the ability to detect and locate dark vessels that manipulate their reported position in order to conceal nefarious activities. Then, BlackSky's satellites automatically tip-and-cue to collect imagery and analyze the images using artificial intelligence to detect vessels, classify each vessel by type, and monitor change over time.

06:47 EDT Avery Dennison promotes Deon Stander to CEO - Avery Dennison announced that its board of directors, as a result of a planned succession process, has elected the company's president and COO, Deon Stander, as president and CEO, effective September 1. Current chairman and CEO, Mitch Butier, will serve as executive chairman of the company's board of directors. Stander joined the company with its acquisition of Paxar Corporation in 2007. He has been president and chief operating officer since March 2022, previously having served as the leader of the Solutions business as well as in a number of other leadership roles based in Europe, Asia and North America. He earned his MBA from Lancaster University in the United Kingdom and his Bachelor of Commerce from the University of Port Elizabeth in South Africa.

06:41 EDT Bank of Montreal increases quarterly dividend to C$1.47 per share - Bank of Montreal announced that its board of directors declared a quarterly dividend of C$1.47 per share on paid-up common shares of Bank of Montreal for the third quarter of FY23, a 4c, or 3%, increase from the prior quarter, up 6% from the prior year.

06:33 EDT QualTek Services announces restructuring transaction to reduce debt by $307M - QualTek Services announced a restructuring transaction that will position it to achieve long-term success in the telecom, renewables, and recovery logistics sectors. The restructuring transaction reduces the Company's debt by approximately $307M and provides $40M of additional liquidity, substantially improving the Company's balance sheet and financial position. To facilitate the financial restructuring, the Company and certain of its subsidiaries have filed voluntarily petitions for Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. QualTek expects significant support of its lenders through this process, including at least 85% of the Company's secured debt holders and approximately 80% of its convertible noteholders. The Company will be filing a Restructuring Support Agreement, or RSA, and Plan of Reorganization, which contemplates that, upon emergence from Chapter 11, there will be new ownership comprised of the Company's existing lenders and management team. The RSA provides a better roadmap for QualTek to emerge swiftly from Chapter 11 with a strong balance sheet and positioned to invest in growth. Under the terms of the RSA, the Company contemplates a $65M debtor-in-possession term loan financing facility, which will include a new money funding of $40M. Upon approval by the Court, the DIP Facility will provide the Company with the stability and liquidity needed to continue operations in the ordinary course of business and pay vendors during the reorganization.

06:23 EDT Infosys announces digital collaboration with Adobe - Infosys (INFY) announced its collaboration with Adobe (ADBE) to transform the digital workforce through Infosys' online learning platform, Infosys Springboard, under its Tech for Good charter. Both organizations will aim to create over 10,000 new Adobe certified experts globally by 2025. Through this engagement, Infosys will help reskill and bridge the skill gap of aspirants by enabling free access to advanced digital learning content offered by Adobe on Infosys Springboard. Aspiring professionals as well as lifelong learners can explore their interests and access Adobe's curriculum to learn more about Adobe Experience Cloud. The collaboration will help deliver corporate learning experiences available on any device and create a pool of upskilled, aspiring professionals.

06:03 EDT Dycom sees Q2 revenue up mid-single digit from last year - The Company expects contract revenues for the quarter ending July 29 to increase mid-single digit as a percentage of contract revenues as compared to the quarter ended July 30, 2022. Non-GAAP Adjusted EBITDA as a percentage of contract revenues for the quarter ending July 29 is expected to increase 50 to 100 basis points as compared to the quarter ended July 30, 2022.

05:11 EDT Corning announces 20% increase to display glass substrate prices - Corning is announcing a 20% increase to its display glass substrate prices. The global price increase will impact all regions, compositions, and glass Gen sizes beginning in the third quarter of 2023. This price adjustment is intended to offset ongoing elevated costs in energy, raw materials, and other non-yen denominated operational expenses during this period of extended inflation which has impacted many global industries, including the display industry. Corning expects growth in demand for display glass in the second half of 2023, driven by the continued recovery of the display industry and typical seasonal demand patterns.

05:05 EDT Gogoro expands partnership with Bikebank in Korea - Gogoro announced it was expanding its partnership with Bikebank in Korea. The companies will introduce Gogoro Smartscooters and battery swapping to Korean consumers in Q3 2023 under the Dotstation brand, expanding their battery swapping network to seven additional cities beyond Seoul. Gogoro Smartscooters and battery swapping have been operating in Seoul for food deliveries since 2019.